Wellington Management Group
GSK icon

Wellington Management Group’s GSK GSK Stock Holding History

Wellington Management Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597M Sell
11,396,249
-321,364
-3% -$17M 0.1% 198
2026
Q1 		$647M Sell
11,717,613
-839,874
-7% -$45.5M 0.12% 178
2025
Q4 		$616M Buy
12,557,487
+9,137,167
+267% +$426M 0.11% 182
2025
Q3 		$148M Buy
3,420,320
+1,965,611
+135% +$76.8M 0.03% 457
2025
Q2 		$55.9M Sell
1,454,709
-463,181
-24% -$17.7M 0.01% 663
2025
Q1 		$74.3M Sell
1,917,890
-176,215
-8% -$6.45M 0.01% 583
2024
Q4 		$70.8M Buy
2,094,105
+190,047
+10% +$6.84M 0.01% 616
2024
Q3 		$77.8M Sell
1,904,058
-159,972
-8% -$6.54M 0.01% 594
2024
Q2 		$79.5M Buy
2,064,030
+493,763
+31% +$20.8M 0.01% 592
2024
Q1 		$67.3M Buy
1,570,267
+526,643
+50% +$21.7M 0.01% 629
2023
Q4 		$38.7M Buy
1,043,624
+131,021
+14% +$4.7M 0.01% 776
2023
Q3 		$33.1M Sell
912,603
-34,918
-4% -$1.24M 0.01% 816
2023
Q2 		$33.8M Sell
947,521
-87,774
-8% -$3.15M 0.01% 815
2023
Q1 		$36.8M Buy
1,035,295
+20,897
+2% +$731K 0.01% 772
2022
Q4 		$35.6M Buy
1,014,398
+210,326
+26% +$7.01M 0.01% 772
2022
Q3 		$23.7M Buy
+804,072
New +$30.5M 0.01% 862
2014
Q1 		– Sell
-515,905
Closed -$34.4M – 2182
2013
Q4 		$34.4M Sell
515,905
-635,120
-55% -$41.2M 0.01% 841
2013
Q3 		$72.2M Sell
1,151,025
-137,920
-11% -$8.88M 0.02% 596
2013
Q2 		$80.5M Buy
+1,288,945
New +$81.8M 0.03% 535

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group's GSK Position: Q2 2026 in Review

Wellington Management Group reduced its GSK (GSK) stake by 2.7% in Q2 2026, selling an estimated $17M and leaving 11,396,249 shares worth $597M. The position accounts for 0.1% of the portfolio, ranked #198.

Wellington Management Group first reported a position in GSK in Q2 2013 and has held it in 19 quarters since. The position peaked at $647M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Wellington Management Group held 11,396,249 shares of GSK worth $597M as of Q2 2026.
  • Wellington Management Group sold 321,364 GSK shares in Q2 2026, an estimated $17M.
  • GSK made up 0.1% of Wellington Management Group's portfolio in Q2 2026, its #198 holding.
  • Wellington Management Group first reported a position in GSK in Q2 2013 and has held it in 19 quarters since.
  • Wellington Management Group's GSK position peaked at $647M in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.